“The 31-GEP Stratifies Risk of Death in Patients with Stage I-IIA Cutaneous Melanoma: A SEER Real-World Evidence Study”, J of Skin, vol. 9, no. 4, p. s586, Jul. 2025, doi: 10.25251/ys9mt689.